Association of physical activity with mortality in chronic kidney disease

Joline L T Chen1, Debra Lerner, Robin Ruthazer

  • 1Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA. joline.chen@bmc.org

Insights

Physical activity did not significantly lower mortality risk in patients with chronic kidney disease (CKD) stages 3-4. Further research is needed to confirm if exercise improves outcomes for CKD patients.

Area of Science:

  • Nephrology
  • Public Health
  • Epidemiology

Background:

  • Chronic kidney disease (CKD) is a significant predictor of mortality.
  • Physical activity is linked to reduced mortality in the general population.
  • The impact of physical activity on mortality in CKD patients (stages 3-4) requires further investigation.

Purpose of the Study:

  • To examine the association between physical activity levels and all-cause mortality in patients with nondiabetic CKD stages 3-4.

Main Methods:

  • 811 patients from the Modification of Diet in Renal Disease (MDRD) Study were analyzed.
  • Baseline physical activity was assessed using indoor activity, exercise, and outdoor activity variables.
  • Cox proportional hazards modeling was used to evaluate the relationship between physical activity and long-term mortality.

Main Results:

  • The study population had a mean age of 52 years, with 61% males and a mean glomerular filtration rate of 32.5 ml/min per 1.73 m2.
  • During follow-up, 24.6% of patients died.
  • Adjusted analyses showed no significant association between indoor activity (HR 0.94), exercise (HR 1.01), or outdoor activity (HR 0.94) and all-cause mortality.

Conclusions:

  • Higher physical activity levels were not significantly associated with reduced long-term mortality in this cohort of CKD patients.
  • Further prospective studies are necessary to validate these findings.
  • The potential benefits of physical activity on outcomes in CKD patients warrant additional research.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...